Category Archives: Annual Reports

Annual Reports

2023 Annual Report

March 28, 2024 Michele Neisemann Comment

2023 Annual Report

Author

Date

BioCurate

March 27, 2024

Annual Report for the year ended 31 December 2023.

The 2023 Annual Report highlights BioCurate’s excellent progress, with milestone success and pipeline growth helping us build a robust portfolio of drug development assets. In particular, the significant growth in our pipeline of early-stage projects was enabled through the expansion of the popular Proof of Concept Scheme with two successful BioCurate Opportunity Application rounds completed, bringing in numerous high-quality opportunities. Pleasingly, all existing Portfolio Projects met key milestones, enabling them to advance to the next stage of development.

BioCurate 2023 Annual Report

Return to News

BioCurate 2021 Annual Report
Read more

BioCurate 2020 Annual Report
Read more

BioCurate 2019 Annual Report
Read more

BioCurate 2018 Annual Report
Read more

Annual Reports

2022 Annual Report

March 30, 2023 Michele Neisemann Comment

2022 Annual Report

Author

Date

BioCurate

March 30, 2023

Annual Report for the year ended 31 December 2022.

The 2022 Annual Report outlines BioCurate progressing the portfolio through key stage gates and growing the pipeline of early-stage projects through an expansion of the Proof of Concept Scheme (POC). A successful fourth round of BioCurate Opportunity Applications (BOA) was completed as well as the generation of novel projects by the BioCurate team. This builds on the strong foundations and positive momentum gained over the previous years towards BioCurate’s mission to commercialise potential therapeutic candidates and create impact on the lives of patients.

BioCurate 2022 Annual Report

Return to News

BioCurate 2020 Annual Report
Read more

BioCurate 2019 Annual Report
Read more

BioCurate 2018 Annual Report
Read more

BioCurate 2017 Annual Report
Read more

Annual Reports

2021 Annual Report

March 30, 2022 Michele Neisemann Comment

2021 Annual Report

Author

Date

BioCurate

March 30, 2022

Annual Report for the year ended 31 December 2021.

The 2021 Annual Report highlights BioCurate’s expansion of the early pipeline and the driving of portfolio projects through key development milestones. This progress towards the BioCurate’s key translation-related goals is the result of strong foundations, the growth and intense focus of the project team, and the partnership with Monash University and the University of Melbourne.

BioCurate 2021 Annual Report

Return to News

BioCurate 2019 Annual Report
Read more

BioCurate 2018 Annual Report
Read more

BioCurate 2017 Annual Report
Read more

Annual Reports

2020 Annual Report

March 31, 2021 Michele Neisemann Comment

2020 Annual Report

Author

Date

BioCurate

March 31, 2021

Annual Report for the year ended 31 December 2020.

The 2020 Annual Report focuses on BioCurate’s successful evaluation of a number of new opportunities and acceleration the progress of projects along their respective development paths, despite the many challenges.

BioCurate 2020 Annual Report

Return to News

BioCurate 2018 Annual Report
Read more

BioCurate 2017 Annual Report
Read more

Annual Reports

2019 Annual Report

March 30, 2020 Michele Neisemann Comment

2019 Annual Report

Author

Date

BioCurate

March 30, 2020

Annual Report for the year ended 31 December 2019.

The 2019 Annual Report focuses on BioCurate’s significant progress with the company’s principal business – building BioCurate’s portfolio and a long-term project pipeline, and improving the understanding of research translation.

BioCurate 2019 Annual Report

Return to News

BioCurate 2017 Annual Report
Read more

Annual Reports

2018 Annual Report

December 3, 2019 Michele Neisemann Comment

2018 Annual Report

Author

Date

BioCurate

April 08, 2019

Annual Report for the year ended 31 December 2018.

The 2018 Annual Report focuses on BioCurate’s significant progress with the company’s principal business – improving the understanding of research translation and accelerating the level and speed at which promising drug discoveries are supported to achieve clinical impact.

BioCurate 2018 Annual Report

Return to News

Inosi Therapeutics launched to tackle fibrosis, based on science from Monash University and support from IP Group and BioCurate
Read more

Annual Reports

2017 Annual Report

November 28, 2019 Michele Neisemann Comment

2017 Annual Report

Author

Date

BioCurate

February 21, 2018

BioCurate Pty Ltd ABN: 67 614 173 278 Annual Report for the year ended 31 December 2017

The 2017 Annual Report focuses on an exciting start BioCurate has made in its quest to develop new medicines, and provides a glimpse of what 2018 has in store.